3rd Annual Bio/Pharmaceutical Anticounterfeiting and ePedigree Summit

When the CA Board of Pharmacy delayed their compliance deadline for the Pharmaceutical ePedigree Law until January 1, 2015, much of the industry put an abrupt stop to their intense drug tracking implementation efforts.  This delay, however, does not indicate that there has been a slow-down in counterfeiting, diversion or illegal importation and has now prompted several states to step-up their efforts in anticounterfeiting and drug tracking.  Additionally, activity on the federal level is highly anticipated by all stakeholders, with some developments already underway and larger initiatives expected in 2010. 

Beyond this, industry is collectively looking for ways to go beyond the supply chain, beyond compliance and drive business value out of anticounterfeiting and ePedigree programs.  Brand and product teams have realized the value that ePedigree systems and applications can play in commercial strategies, but the commercial and business applications that can be derived from these systems are in their infancy and require thought leadership to successfully move forward.

At CBI’s 3^rd Annual Bio/Pharmaceutical Anticounterfeiting and ePedigree Summit, delegates get a holistic view of the anticounterfeiting and ePedigree landscape to achieve compliance and drive business value through commercial applications of ePedigree systems. 

Program highlights include:

• Policy Outlook – U.S. Federal and State Legislation and Guidance Update
• Global Anticounterfeiting, Antidiversion and Supply Chain Integrity Update
• Determining the Appropriate Technologies and Level for Serialization
• Drug Traceability – Collaborating with Trade Partners Up and Down the Supply Chain
• Benchmarking and Lessons Learned from Consumer Markets
• What’s Next?  Planning Strategies for CROs, CMOs, 3PLs and Virtual Pharma
• Strategic Commercial Initiatives – Creating A Win-Win Relationship between Compliance and Business Value

Here’s what some of the 2009 delegates had to say:

“Excellent coverage of latest laws, regulations, technology and systems!”
– C. Matthews, Ph.D., Senior Sourcing Manager, Johnson & Johnson

“This is the place to be to learn and know what the industry in USA and rest of the world is doing to improve our life.”
– Shashi Banda, Senior Manager Business Technology and Trade, Pfizer

“CBI chose quality, informed speakers that made the trip well worth my while.”
– Kevin Burke, Senior R&D Engineer, Covidien

For more information or to register, please contact the Center for Business Intelligence toll free by phone at 1-800-817-8601 or via e-mail at cbireg@cbinet.com.